Watanabe T, Matsuhashi K, Takayama S
Drug Safety Research Center, Daiichi Pharmaceutical Co., Ltd., Tokyo, Japan.
Yakubutsu Seishin Kodo. 1990 Sep;10(3):351-62.
In order to determine behavioral teratogenesis of fetal and neonatal exposures to chlorpromazine (CPZ) in rats, conditioned avoidance learning by shuttle box in pups was examined. CPZ was administered sc to pregnant and nursing rats during fetal organogenesis period (on days 11-15 of gestation, at doses of 9, 21 mg/kg/day), perinatal period (on days 16-20 of gestation, at 9, 18 mg/kg/day), and nursing period (on days 1-10 postpartum, at 9, 18 mg/kg/day). The results showed that high doses of CPZ during all periods caused learning impairment in pups, although learning impairment by the exposures during fetal organogenesis and nursing periods was stronger than that of perinatal exposure and pattern of learning impairment was different between the former and the latter. Exposure to CPZ during fetal organogenesis period induced an increase in norepinephrine and dopamine concentrations in the hippocampus of pups. Thus it is clear that developmental treatment with CPZ produced learning impairment. Furthermore, CPZ transferred rapidly into fetal and neonatal brains. Our results suggest that blood-brain barrier transfer of CPZ is a major factor in behavioral teratogenesis.
为了确定大鼠胎儿期和新生儿期接触氯丙嗪(CPZ)的行为致畸作用,检测了幼崽在穿梭箱中的条件性回避学习情况。在胎儿器官形成期(妊娠第11 - 15天,剂量为9、21毫克/千克/天)、围产期(妊娠第16 - 20天,剂量为9、18毫克/千克/天)以及哺乳期(产后第1 - 10天,剂量为9、18毫克/千克/天),对怀孕和哺乳的大鼠皮下注射CPZ。结果表明,所有时期高剂量的CPZ都会导致幼崽学习障碍,尽管胎儿器官形成期和哺乳期接触CPZ导致的学习障碍比围产期接触更强,且前两者的学习障碍模式有所不同。胎儿器官形成期接触CPZ会导致幼崽海马体中去甲肾上腺素和多巴胺浓度升高。因此,显然CPZ的发育治疗会导致学习障碍。此外,CPZ能迅速转移至胎儿和新生儿大脑。我们的结果表明,CPZ的血脑屏障转移是行为致畸的一个主要因素。